ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 244 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,812,620 | -37.8% | 71,363 | -0.7% | 0.02% | -38.5% |
| Q4 2022 | $2,913,546 | +52.5% | 71,833 | +24.2% | 0.03% | +44.4% |
| Q3 2022 | $1,911,000 | -13.5% | 57,826 | -7.8% | 0.02% | -14.3% |
| Q2 2022 | $2,209,000 | -60.7% | 62,730 | -51.9% | 0.02% | -74.7% |
| Q3 2020 | $5,617,000 | -6.3% | 130,451 | -6.0% | 0.08% | +3.8% |
| Q2 2020 | $5,997,000 | +698.5% | 138,841 | +1072.3% | 0.08% | +1233.3% |
| Q4 2019 | $751,000 | +115.8% | 11,843 | -4.2% | 0.01% | +100.0% |
| Q3 2019 | $348,000 | -58.5% | 12,357 | -89.4% | 0.00% | -57.1% |
| Q1 2018 | $839,000 | +175.1% | 116,402 | +40.5% | 0.01% | +250.0% |
| Q4 2017 | $305,000 | – | 82,856 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
| Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
| M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
| WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
| Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
| Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
| JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
| COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
| Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
| Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |